Besides, the combination of PD-1/PD-L1 and CTLA-4 for advanced non-small cell lung cancer is currently a prominent research focus, although its clinical applicability has not achieved consensus. The gene discussed is CTLA4; the disease is non-small cell lung carcinoma.